XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   53,682,117    
Beginning balance at Dec. 31, 2023 $ 561,365 $ 537 $ 1,540,859 $ (980,031)
Share-based compensation 12,383   12,383  
Issuance of ordinary shares upon exercise of stock options (in shares)   38,338    
Stock Issued During Period, Value, Stock Options Exercised 890   890  
Net Income (Loss) (72,239)     (72,239)
Ending balance (in shares) at Mar. 31, 2024   53,720,455    
Ending balance at Mar. 31, 2024 502,399 $ 537 1,554,132 (1,052,270)
Beginning balance (in shares) at Dec. 31, 2023   53,682,117    
Beginning balance at Dec. 31, 2023 561,365 $ 537 1,540,859 (980,031)
Net Income (Loss) (64,354)      
Ending balance (in shares) at Sep. 30, 2024   53,808,732    
Ending balance at Sep. 30, 2024 534,362 $ 538 1,578,209 (1,044,385)
Beginning balance (in shares) at Mar. 31, 2024   53,720,455    
Beginning balance at Mar. 31, 2024 502,399 $ 537 1,554,132 (1,052,270)
Share-based compensation 12,041   12,041  
Issuance of ordinary shares upon exercise of stock options (in shares)   51,390    
Stock Issued During Period, Value, Stock Options Exercised 591 $ 1 590  
Net Income (Loss) 66,886     66,886
Ending balance (in shares) at Jun. 30, 2024   53,771,845    
Ending balance at Jun. 30, 2024 581,917 $ 538 1,566,763 (985,384)
Share-based compensation 11,020   11,020  
Issuance of ordinary shares upon exercise of stock options (in shares)   35,887    
Stock Issued During Period, Value, Stock Options Exercised 426 $ 0 426  
Issuance of ordinary shares upon vesting of restricted stock units (in shares)   1,000    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 0 $ 0 0  
Net Income (Loss) (59,001)     (59,001)
Ending balance (in shares) at Sep. 30, 2024   53,808,732    
Ending balance at Sep. 30, 2024 534,362 $ 538 1,578,209 (1,044,385)
Beginning balance (in shares) at Dec. 31, 2024   53,826,982    
Beginning balance at Dec. 31, 2024 486,926 $ 538 1,588,729 (1,102,341)
Share-based compensation 10,949   10,949  
Net Income (Loss) (60,195)     (60,195)
Ending balance (in shares) at Mar. 31, 2025   53,826,982    
Ending balance at Mar. 31, 2025 437,680 $ 538 1,599,678 (1,162,536)
Beginning balance (in shares) at Dec. 31, 2024   53,826,982    
Beginning balance at Dec. 31, 2024 $ 486,926 $ 538 1,588,729 (1,102,341)
Issuance of ordinary shares upon exercise of stock options (in shares) 0      
Net Income (Loss) $ (222,503)      
Ending balance (in shares) at Sep. 30, 2025   53,829,982    
Ending balance at Sep. 30, 2025 294,989 $ 538 1,619,295 (1,324,844)
Beginning balance (in shares) at Mar. 31, 2025   53,826,982    
Beginning balance at Mar. 31, 2025 437,680 $ 538 1,599,678 (1,162,536)
Share-based compensation 12,418   12,418  
Net Income (Loss) (125,767)     (125,767)
Ending balance (in shares) at Jun. 30, 2025   53,826,982    
Ending balance at Jun. 30, 2025 324,331 $ 538 1,612,096 (1,288,303)
Share-based compensation 7,199   7,199  
Issuance of ordinary shares upon vesting of restricted stock units (in shares)   3,000    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 0 $ 0 0  
Net Income (Loss) (36,541)     (36,541)
Ending balance (in shares) at Sep. 30, 2025   53,829,982    
Ending balance at Sep. 30, 2025 $ 294,989 $ 538 $ 1,619,295 $ (1,324,844)